Is it the Systemic Inflammatory Response Syndrome or Endotoxemia in Horses with Colic?

Veterinary Clinics of North America - Equine Practice

Volumn 30, Issue 2, 2014, Pages 337-351

  Moore, James N ^a   Vandenplas, Michel L ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE   (Saint Kitts and Nevis)

Author keywords

Endotoxin; Innate immunity; Lipopolysaccharide; Systemic inflammation; Toll like receptors

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR;

ANIMAL; ANIMAL DISEASE; COLIC; DIFFERENTIAL DIAGNOSIS; ENDOTOXEMIA; HORSE; HORSE DISEASE; INNATE IMMUNITY; NEWBORN; REVIEW; SYSTEMIC INFLAMMATION;

ENDOTOXIN; INNATE IMMUNITY; LIPOPOLYSACCHARIDE; SYSTEMIC INFLAMMATION; TOLL-LIKE RECEPTORS;

ANIMALS; ANIMALS, NEWBORN; COLIC; DIAGNOSIS, DIFFERENTIAL; ENDOTOXEMIA; HORSE DISEASES; HORSES;

EID: 84904048426     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2014.04.003     Document Type: Review

References (55)

1. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
2. Corley K.T., Donaldson L.L., Furr M.O. Arterial lactate concentration, hospital survival, sepsis and SIRS in critically ill neonatal foals. Equine Vet J 2005, 37:53-59.
3. Epstein K.L., Brainard B.M., Gomez-Ibanez S.E., et al. Thrombelastography in horses with acute gastrointestinal disease. J Vet Intern Med 2011, 25(2):307-314.
4. Belknap J.K., Black S.J. Sepsis-related laminitis. Equine Vet J 2012, 44:738-740.
5. Giguere S., Cohen N.D., Chaffin M.K., et al. Rhodococcus equi: Clinical manifestations, virulence and immunity. J Vet Intern Med 2011, 25:1221-1230.
6. Werners A.H., Bryant C.E. Pattern recognition receptors in equine endotoxaemia and sepsis. Equine Vet J 2012, 44:490-498.
7. Bryant C.E., Monie T.P. Mice, men and the relatives: cross-species studies underpin innate immunity. Open Biol 2012, 2(4):120015.
8. Astakhova N.M., Perelygin A.A., Zharkikh A.A., et al. Characterization of equine and other vertebrate TLR3, TLR7, and TLR8 genes. Immunogenetics 2009, 61:529-539.
9. Gornik K., Moore P., Figueiredo M., et al. Expression of Toll-like receptors 2, 3, 4, 6, 9, and MD-2 in the normal equine cornea, limbus, and conjunctiva. Vet Ophthalmol 2011, 14:80-85.
10. Lohmann K.L., Vandenplas M.L., Barton M.H., et al. The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist. J Endotoxin Res 2007, 13(4):235-242.
11. Zhang Y.W., Davis E.G., Blecha F., et al. Molecular cloning and characterization of equine Toll-like receptor 9. Vet Immunol Immunopathol 2008, 124:209-219.
12. Quintana A.M., Landolt G.A., Annis K.M., et al. Immunological characterization of the equine airway epithelium and of a primary equine airway epithelial cell culture model. Vet Immunol Immunopathol 2011, 140:226-236.
13. Figueiredo M.D., Vandenplas M.L., Hurley D.J., et al. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists. Vet Immunol Immunopathol 2009, 127:125-134.
14. Kwon S., Gewirtz A.T., Hurley D.J., et al. Disparities in TLR5 expression and responsiveness to flagellin in equine neutrophils and mononuclear phagocytes. J Immunol 2011, 186:6263-6270.
15. Flaminio M.J., Borges A.S., Nydam D.V., et al. The effect of CpG-ODN on antigen presenting cells of the foal. J Immune based Therap Vacc 2007, 5:1.
16. Trent M.S., Stead C.M., Tran A.X., et al. Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res 2006, 12:205-223.
17. Schumann R.R. Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans 2011, 39:989-993.
18. Szatmary Z. Molecular biology of toll-like receptors. Gen Physiol Biophys 2012, 31:357-366.
19. Brikos C., O'Neill L.A. Signalling of toll-like receptors. Handb Exp Pharmacol 2008, (183):21-50.
20. Siegemund S., Sauer K. Balancing pro- and anti-inflammatory TLR4 signaling. Nat Immunol 2012, 13:1031-1033.
21. Aksoy E., Taboubi S., Torres D., et al. The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat Immunol 2012, 13:1045-1054.
22. Darrah P.A., Monaco M.C., Jain S., et al. Innate immune responses to Rhodococcus equi. J Immunol 2004, 173:1914-1924.
23. Cheevers W.P., Archer B.G., Crawford T.B. Characterization of RNA from equine infectious anemia virus. J Virol 1977, 24:489-497.
24. Lambert A.J., Martin D.A., Lanciotti R.S. Detection of North American Eastern and Western equine encephalitis viruses by nucleic acid amplification assays. J Clin Microbiol 2003, 41(1):379-385.
25. Mottahedin A., Paidikondala M., Cholleti H., et al. NF-κB activation by equine arteritis virus is MyD88 dependent and promotes viral replication. Arch Virol 2013, 158(3):701-705.
26. Rahman M.M., McFadden G. Modulation of NF-kB signaling by microbial pathogens. Nat Rev Microbiol 2011, 9:291-306.
27. Wilson J.R., de Sessions P.F., Leon M.A., et al. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol 2008, 82(17):8262-8271.
28. Liu J., Xu C., Hsu L.C., et al. A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition. Mol Immunol 2010, 47:1083-1090.
29. Liu M., Liu T., Bordin A., et al. Activation of foal neutrophils at different ages by CpG oligodeoxynucleotides and Rhodococcus equi. Cytokine 2009, 48:280-289.
30. Sun W.C., Moore J.N., Hurley D.J., et al. Effects of stimulation of adenosine A2A receptors on lipopolysaccharide-induced production of reactive oxygen species by equine neutrophils. Am J Vet Res 2007, 68:649-656.
31. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30:475-487.
32. Kwon S., Vandenplas M.L., Figueiredo M.D., et al. Differential induction of Toll-like receptor gene expression in equine monocytes activated by Toll-like receptor ligands or TNF-α. Vet Immunol Immunopathol 2010, 138:213-217.
33. Walsh C., Gangloff M., Monie T., et al. Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J Immunol 2008, 181:1245-1254.
34. Bryant C.E., Ouellette A., Lohmann K., et al. The cellular Toll-like receptor 4 antagonist E5531 can act as an agonist in horse whole blood. Vet Immunol Immunopathol 2007, 116:182-189.
35. Figueiredo M.D., Moore J.N., Vandenplas M.L., et al. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes. Am J Vet Res 2008, 69:796-803.
36. Reitschel E.T., Cavaillon J.M. Richard Pfeiffer and Alexandre Besredka: creators of the concept of endotoxin and anti-endotoxin. Microbes Infect 2003, 5:1407-1414.
37. Coley W.B. The treatment of malignant tumors by repeated inoculations of erysipelas, with a report of ten original cases. Am J Med Sci 1893, 105:487-511.
38. Hill A.B., Hatswell J.M., Topley W.W. The inheritance of resistance, demonstrated by the development of a strain of mice resistant to experimental inoculation with a bacterial endotoxin. J Hyg 1940, 40:538-547.
39. Burrows G.E. Endotoxemia induced by rapid intravenous injection of Escherichia coli in anesthetized ponies. Am J Vet Res 1970, 31:1967-1973.
40. Aggarwal B.B., Gupta S.C., Kim J.H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 2012, 119:651-665.
41. MacKay R.J. Association between serum cytotoxicity and selected clinical variables in 240 horses admitted to a veterinary hospital. Am J Vet Res 1992, 53(5):748-752.
42. Collatos C., Barton M.H., Prasse K.W., et al. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases. J Am Vet Med Assoc 1995, 207:465-470.
43. Barton M.H., Parviainien A., Norton N. Polymyxin B protects horses against induced endotoxemia in vivo. Equine Vet J 2004, 36:397-401.
44. Hoshino K., Takeuchi O., Kawai T., et al. Cutting Edge: Toll-like receptor 4 deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 1999, 162:3749-3752.
45. Lopes M.A., Salter C.E., Vandenplas M.L., et al. Expression of inflammation-associated genes in circulating leukocytes collected from horses with gastrointestinal tract disease. Am J Vet Res 2010, 71:915-924.
46. Leise B.S., Faleiros R.R., Watts M., et al. Laminar inflammatory gene expression in the carbohydrate overload model of equine laminitis. Equine Vet J 2011, 43:54-61.
47. Barton M.H., Morris D.D., Norton N., et al. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia. J Vet Intern Med 1998, 12:26-35.
48. Steverink P., Sturk A., Rutten V., et al. Endotoxin, interleukin-6 and tumor necrosis factor concentrations in equine acute abdominal disease - relation to clinical outcome. J Endotoxin Res 1995, 2:289-299.
49. Senior J.M., Proudman C.J., Leuwer M., et al. Plasma endotoxin in horses presented to an equine referral hospital: correlation to selected clinical parameters and outcomes. Equine Vet J 2011, 43:585-591.
50. Kane T.D., Alexander J.W., Johannigman J.A. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients. Ann Surg 1998, 227:1-9.
51. Liaudet L., Szabo C., Evgenov O.V., et al. Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock 2003, 19:131-137.
52. Sitaraman S.V., Klapproth J.M., Moore D.A., et al. Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2005, 288:G403-G406.
53. Lodes M.J., Cong Y., Elson C.O., et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004, 113:1296-1306.
54. Sykes B.W., Furr M.O. Equine endotoxaemia - a state-of-the-art review of therapy. Aust Vet J 2005, 83:45-50.
55. Seok J., Warren H.S., Cuenca A.G., et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013, 110:3507-3512.